The costs of chronic obstructive pulmonary disease (COPD) pose a major economic burden
to the United States. Studies evaluating COPD costs have generated widely variable …

Chronic obstructive pulmonary disease (COPD) is a leading cause of death and disability
worldwide. The Global Burden of Disease study has concluded that COPD will become the …

Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are a leading
cause of hospitalizations in the United States and the major cost driver of COPD. This study …

Rational and appropriate antibiotic use for patients with acute exacerbation of chronic
bronchitis (AECB) is a major concern, as approximately half of these patients do not have a …

Purpose Chronic obstructive pulmonary disease (COPD) is a prevalent condition mainly
related to smoking, which is associated with a substantial economic burden. The purpose …

Background Chronic bronchitis (CB) is often misdiagnosed or diagnosed at a later stage of
chronic obstructive pulmonary disease (COPD). We examined how this later diagnosis may …

Asthma und COPD haben weltweit eine hohe und wachsende epidemiologische
Bedeutung, und es gibt zahlreiche Hinweise auf hohe damit verbundene …

Background Lymphocyte alterations have been associated with an increased prevalence of
acute respiratory infections in COPD patients. AM3 is an oral immunomodulator that …

Objective: To compare risk of hospitalization or emergency department (ED) visit and
healthcare costs in patients with chronic bronchitis initiating inhaled maintenance therapy …

Haemophilus influenzae is the most common bacterial pathogen associated with acute
exacerbations of chronic bronchitis (AECB). This study determined the rate of bacterial …